| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCGCCCGCCCACUGGGCCCCGGGGCGGCCGGCGGCCGGGUCUCUCGGGC… | 1883 nt | 0.5805 | |
| GUUAGUCCCCGCGCGGCGAGGACGGGGCGGCGGGGGCGCAGGGCCUGGA… | 2057 nt | 0.5868 | |
| GCGCCCGCCCACUGGGCCCCGGGGCGGCCGGCGGCCGGGUCUCUCGGGC… | 1781 nt | 0.5794 | |
| ACAGCGCACCGGGCCGGGGGAGCGGCCGCGCUGGGCCGGGCGGGCGGGU… | 2114 nt | 0.6008 |
Predicted to be involved in regulation of myoblast fusion. Predicted to act upstream of or within several processes, including lamellipodium morphogenesis; myoblast fusion; and myoblast migration. Predicted to be located in cytoplasm; nucleus; and plasma membrane. Predicted to be active in muscle cell projection membrane and ruffle membrane. [provided by Alliance of Genome Resources, Jul 2025]
A study in human neonates with hypoxic-ischemic encephalopathy (HIE) demonstrated that the PLEKHO1 was the most significant gene differentially expressed between neonates with HIE and healthy controls over time in a high-income country cohort [Montaldo et al. DOI:10.1001/jamanetworkopen.2023.54433]. In a separate investigation using a rhesus macaque model of hypertrophic cardiomyopathy, the PLEKHO1 was identified as a shared upregulated differentially expressed gene between the non-human primate model and pediatric human HCM [Rivas et al. DOI:10.1038/s41598-024-82770-4].